MedPath

Project Healthy Eating in Children. A Study on the Health Effects of Fish Intake in Overweight Children

Terminated
Conditions
Healthy
Interventions
Other: Cod Group
Other: Salmon Group
Other: Meat Group
Registration Number
NCT02025933
Lead Sponsor
University of Bergen
Brief Summary

It has previously been seen that increased fish intake improves the metabolic health of overweight and obese adults, and animal protein improved metabolic health of obese rats. In this project the investigators will investigate whether increased intake of fish or meat improve metabolic health in children aged 9-12 years as well when replacing processed food. The hypothesis is that increased intake of unprocessed fish or meat will improve metabolic health in children as measured by glucose tolerance, lipid metabolism and inflammatory markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • overweight (iso-BMI > 25)
  • 9-12 years
  • healthy
Exclusion Criteria
  • diagnosed diseases such as diabetes, CVD, intestinal diseases, arthritis
  • prescription medications affecting the metabolism of glucose, lipids or the immune system
  • use of supplements containing long chain n-3 fatty acids
  • high intake of fish
  • food allergy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cod GroupCod GroupParticipants will eat 75-150 grams of cod for dinner, three times a week for 12 weeks.
Salmon GroupSalmon GroupParticipants will eat 75 - 150 grams of salmon for dinner, three times a week for 12 weeks.
Meat GroupMeat GroupParticipants will eat 75-150 grams of mixed meat for dinner, three times a week for 12 weeks.
Primary Outcome Measures
NameTimeMethod
Changes in metabolic status (glucose, lipids, inflammation)Baseline and end of intervention period (12 weeks)

We will investigate any changes in the metabolic status by analyzing parameters affected by changes in glucose homeostasis, lipid metabolism and inflammation.

Secondary Outcome Measures
NameTimeMethod
Body compositionBaseline and end of intervention (12 weeks)

Trial Locations

Locations (1)

University of Bergen

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath